FDA Approves Novel Self-Injection Treatment for Migraines

FDA Approves Novel Self-Injection Treatment for Migraines

Is your relationship, work, and overall lifestyle being affected by non-relenting, stabbing headaches? There’s now a new answer on the market.

If you suffer from migraines, you know finding lasting relief can be tough. Depending on the person, it could be a dark room and sleep that provides some comfort, a doctor’s prescription or over-the-counter migraine medication.

However, it could be that you have yet to find the answer. Maybe this is it: a new solution has just been approved by the FDA, and it’s said to provide pain solutions for those who suffer from episodic migraines, as well as chronic ones.

It’s a drug called Aimovig. Patients administer it themselves in once-a-month self-injections.

Related: This New Drug Could Take Away Your Migraines Completely

The treatment is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule experts say is involved in migraine attacks.

Migraine pain is often described as intense pulsing or throbbing pain that takes place in just one area of your head. Some people who suffer from them also experience nausea and vomiting, as well as a sensitivity to light and sound.

Women are up to 3 times more likely to have migraines than men, which could be due to hormonal changes.

About one-third of migraine patients also experience an aura before their headache hits. It can appear as flashing lights, zig-zag lines, or a temporary loss of vision.

If you suffer from migraines, speak to your doctor about solutions.

Photo credits: Horoscope/Shutterstock.com

Facebook Comments